Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
04/22/1997 | US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells |
04/22/1997 | US5622934 Treating diabetes mellitus |
04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
04/22/1997 | US5622828 Contacting mixture of nucleic acids with secretory phospholipase a2, partitioning increased affinity nucleic acids, amplifying |
04/22/1997 | CA2031265C Methods of detecting collagen degradation in vivo |
04/17/1997 | WO1997013783A1 An acceptor polypeptide for an n-acetylgalactosaminyltransferase |
04/17/1997 | WO1997013493A1 Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss |
04/17/1997 | WO1997013410A1 Hybrid molecules containing amidated polypeptide binding ligands |
04/17/1997 | WO1996028468A3 Amphiphilic peptide and analogs thereof |
04/16/1997 | EP0768318A2 Peptide having collagen contraction inhibiting activity |
04/16/1997 | EP0767835A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
04/16/1997 | EP0767801A1 Endothelin antagonists ii |
04/16/1997 | CN1147819A New opioid peptide analogs with mixed MU agonist/delta antagonist properties |
04/16/1997 | CN1034577C Producing process for peptides having bradykinin-antagonistic action |
04/15/1997 | US5621076 Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
04/15/1997 | US5620959 Bombesin antagonists |
04/15/1997 | US5620958 Bradykinin antagonists |
04/15/1997 | US5620957 Hemoregulatory peptides |
04/15/1997 | US5620956 Inhibiting differentiation of cytotoxic t-lymphocyte precursor to mature cell specific for foreign antigen |
04/15/1997 | US5620955 Synthetic peptide derivatives; inhibit growth of small cell lung cancer or pancreatic cells |
04/15/1997 | US5620954 Peptide compositions and uses therefor |
04/15/1997 | US5620688 Methods of inhibiting the activation of Factor XIII |
04/15/1997 | US5620675 Medical diagnosis |
04/10/1997 | WO1997012988A1 Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins |
04/10/1997 | WO1997012850A2 Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes |
04/10/1997 | WO1997012636A2 Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes |
04/10/1997 | WO1997012624A1 Novel peptides |
04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
04/10/1997 | CA2233272A1 Novel peptides |
04/10/1997 | CA2232620A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as xsny for radioactive isotopes |
04/10/1997 | CA2232315A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as s2 ny for radioactive isotopes |
04/10/1997 | CA2187485A1 Peptide and collagen contraction inhibitor |
04/09/1997 | EP0766737A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
04/09/1997 | EP0766736A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
04/09/1997 | EP0548217B1 Process for the preparation of c-terminally amidated peptides |
04/09/1997 | CN1147261A Factor Xa inhibitors |
04/09/1997 | CN1034506C Method for preparing medicinal composition contg. glycopeptide derivs. |
04/08/1997 | USRE35492 Wound treatment employing biologically active ion channel forming peptides and proteins |
04/08/1997 | US5618914 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
04/08/1997 | US5618791 Reduced side effects |
04/08/1997 | US5618787 Cyclic peptide antifungal agents |
04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
04/08/1997 | US5618528 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
04/03/1997 | WO1997012048A1 Recombinant viruses incorporating a protease cleavable protein |
04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
04/03/1997 | WO1997011962A1 Cyclic peptide analogs of somatostatin |
04/03/1997 | WO1997011959A1 Biologically active mhc peptides having a repeated amino acid sequence motif |
04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
04/03/1997 | WO1996038473A3 Antimicrobial cationic peptides |
04/03/1997 | CA2232669A1 Recombinant viruses incorporating a protease cleavable protein |
04/02/1997 | EP0765478A1 Positive and positive/negative cell selection mediated by peptide release |
04/02/1997 | EP0765341A1 Template directed cyclization |
04/02/1997 | EP0765165A1 Constrained peptides |
04/02/1997 | CN1146771A Piptide fragments and analogs derived from pBAN 1-33 NHz for controlling moths |
04/02/1997 | CN1146726A Block copolymers |
04/02/1997 | CN1146458A Cardiovascular active polypeptide and its synthesis and medical use |
04/01/1997 | US5616685 snRNP-A antigen and fragments thereof |
04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
04/01/1997 | US5616595 Concentration, solubilizing, diafiltration in a closed recirculation system |
04/01/1997 | US5616556 Method of treating rheumatoid arthritis and osteoarthrosis using tetrahydro WS9326A |
04/01/1997 | US5616327 M-protein peptides of influenza virus as antiviral agents |
04/01/1997 | US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
04/01/1997 | CA1339043C Nonapeptide and decapetide analogs of lhrh useful as lhrh antagonists |
03/27/1997 | WO1997011092A1 Cyclosporin phosphate derivatives and medicinal composition |
03/27/1997 | WO1997010853A2 N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes |
03/27/1997 | WO1997010851A2 Nucleic acid delivery vehicle |
03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
03/27/1997 | WO1997010836A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras |
03/27/1997 | WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
03/27/1997 | WO1997010711A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
03/27/1997 | DE19536785A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ S¶2¶NY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent S¶2¶NY for radioactive isotopes |
03/27/1997 | DE19536783A1 Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope Bifunctional nicotinamide-type chelating agent N¶2¶S¶2¶ for radioactive isotopes |
03/27/1997 | DE19536780A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent XSNY for radioactive isotopes |
03/27/1997 | CA2232750A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras |
03/27/1997 | CA2232340A1 Bifunctional nicotinamide-chelating agents such as n2s2 for radioactive isotopes |
03/27/1997 | CA2231172A1 Nucleic acid delivery vehicle |
03/27/1997 | CA2230119A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
03/27/1997 | CA2227306A1 Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection |
03/26/1997 | EP0764203A1 Methods for selectively stimulating proliferation of t cells |
03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
03/26/1997 | EP0642531B1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method |
03/26/1997 | EP0482080B1 Small cyclic platelet aggregation inhibitors |
03/26/1997 | CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases |
03/25/1997 | US5614499 Anticoagulants; treatment or prophylaxis of thrombosis |
03/25/1997 | US5614497 Treatment of hypertension, cardiovascular disease and renal disease |
03/25/1997 | US5614494 Peptides for heparin and low molecular weight heparin anticoagulation reversal |
03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
03/25/1997 | CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof |
03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
03/20/1997 | WO1997010264A1 Cyclic hexapeptide compounds |
03/20/1997 | WO1997010263A1 Actinomycin d analogues |
03/20/1997 | WO1997010261A1 Peptide derivatives |
03/20/1997 | WO1997009995A1 Method for reducing the severity of gastro-intestinal damage |
03/20/1997 | WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof |
03/20/1997 | CA2232140A1 Cyclic hexapeptide compound |
03/20/1997 | CA2231174A1 Peptide derivatives |